Greenwood Capital Associates’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
RHJA
KCM
PHP
Greenwood Capital Associates's OPRX Position: Q1 2025 in Review
Greenwood Capital Associates sold out of OptimizeRx (OPRX) in Q1 2025, closing a stake of 88,596 shares — an estimated $431K sold.
Greenwood Capital Associates first reported a position in OPRX in Q3 2020 and held it in 18 quarters. The position peaked at $2.13M in Q3 2021. 87 funds tracked by Wall St. Rank hold OPRX as of Q1 2025.
- Greenwood Capital Associates reported no remaining OptimizeRx position as of Q1 2025 after selling out during the quarter.
- Greenwood Capital Associates sold 88,596 OptimizeRx shares in Q1 2025, an estimated $431K.
- Greenwood Capital Associates first reported a position in OptimizeRx in Q3 2020 and held it in 18 quarters.
- Greenwood Capital Associates's OptimizeRx position peaked at $2.13M in Q3 2021.
- 87 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2025.
Based on Greenwood Capital Associates's 13F filing for Q1 2025, filed 15 Apr 2025.